Bicara Therapeutics Inc
NASDAQ:BCAX
Balance Sheet
Balance Sheet Decomposition
Bicara Therapeutics Inc
Bicara Therapeutics Inc
Balance Sheet
Bicara Therapeutics Inc
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
4
|
230
|
490
|
|
| Cash Equivalents |
4
|
230
|
490
|
|
| Other Current Assets |
1
|
1
|
13
|
|
| Total Current Assets |
5
|
231
|
503
|
|
| PP&E Net |
1
|
1
|
1
|
|
| Other Long-Term Assets |
1
|
2
|
7
|
|
| Total Assets |
7
N/A
|
234
+3 391%
|
510
+118%
|
|
| Liabilities | ||||
| Accounts Payable |
5
|
3
|
5
|
|
| Accrued Liabilities |
19
|
12
|
13
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Total Current Liabilities |
24
|
15
|
18
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
|
| Total Liabilities |
24
N/A
|
15
-35%
|
18
+17%
|
|
| Equity | ||||
| Common Stock |
82
|
367
|
0
|
|
| Retained Earnings |
101
|
153
|
221
|
|
| Additional Paid In Capital |
2
|
4
|
713
|
|
| Total Equity |
17
N/A
|
219
N/A
|
492
+125%
|
|
| Total Liabilities & Equity |
7
N/A
|
234
+3 391%
|
510
+118%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
52
|
52
|
54
|
|